CE approval has been received for the world's first applicators manufactured by 3D printing and designed for the treatment of gynecological tumors.

A joint venture has been formed in China for the development, production and distribution of advanced tumor irradiation devices highly effective against gynecological and other forms of cancer.

Market clearance has been received from the U.S. Food and Drug Administration (FDA) for its new SagiNova® afterloader.

For the first time, a system designed to provide radiation in treating gynecological tumors with brachytherapy sources has been installed in a hospital in Addis Ababa, the capital of Ethiopia, as part of a United Nations aid program for expanding healthcare in Africa. Brachytherapy involves miniaturized, wire-guided radiation sources placed at the site of the tumor, which are especially effective in treating cervical cancer.

100% of the shares in Mick Radio Nuclear Instruments, Inc. (MRNI), one of the leading manufacturers of brachytherapy instrumentation and accessories, has been acquired. The company is based in the US state of New York and generated sales of approximately €4 million in fiscal year 2012/2013. A non-disclosure agreement has been reached regarding the price of the purchase.

A tender has been won to equip Bangladeshi cancer clinics with modern cancer irradiation equipment.